"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","source_name_ch2","organism_ch2","characteristics_ch2","molecule_ch2","extract_protocol_ch2","label_ch2","label_protocol_ch2","taxid_ch2","hyb_protocol","scan_protocol","description","description.1","description.2","description.3","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_fax","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","supplementary_file.1","supplementary_file.2","data_row_count"
"GSM307294","tumor sample 160","GSM307294","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307294/GSM307294.gpr.gz","","","33091"
"GSM307295","tumor sample 203","GSM307295","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CC(N)","Stage: T2N1","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307295/GSM307295.gpr.gz","","","33091"
"GSM307296","tumor sample 204","GSM307296","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307296/GSM307296.gpr.gz","","","33091"
"GSM307297","tumor sample 205","GSM307297","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CA","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307297/GSM307297.gpr.gz","","","33091"
"GSM307298","tumor sample 206","GSM307298","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307298/GSM307298.gpr.gz","","","33091"
"GSM307299","tumor sample 209","GSM307299","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307299/GSM307299.gpr.gz","","","33091"
"GSM307300","tumor sample 215","GSM307300","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307300/GSM307300.gpr.gz","","","33091"
"GSM307301","tumor sample 217","GSM307301","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307301/GSM307301_H059A4_2color.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307301/GSM307301_H059H8.gpr.gz","","33091"
"GSM307302","tumor sample 219","GSM307302","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CA","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307302/GSM307302.gpr.gz","","","33091"
"GSM307303","tumor sample 220","GSM307303","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307303/GSM307303.gpr.gz","","","33091"
"GSM307304","tumor sample 221","GSM307304","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307304/GSM307304.gpr.gz","","","33091"
"GSM307305","tumor sample 510","GSM307305","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307305/GSM307305.gpr.gz","","","33091"
"GSM307306","tumor sample 511","GSM307306","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307306/GSM307306.gpr.gz","","","33091"
"GSM307307","tumor sample 514","GSM307307","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307307/GSM307307.gpr.gz","","","33091"
"GSM307308","tumor sample 515","GSM307308","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307308/GSM307308.gpr.gz","","","33091"
"GSM307309","tumor sample 525","GSM307309","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307309/GSM307309.gpr.gz","","","33091"
"GSM307310","tumor sample 528","GSM307310","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: TisN0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307310/GSM307310.gpr.gz","","","33091"
"GSM307311","tumor sample 533","GSM307311","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307311/GSM307311.gpr.gz","","","33091"
"GSM307312","tumor sample 534","GSM307312","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CA","Stage: T3N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307312/GSM307312.gpr.gz","","","33091"
"GSM307313","tumor sample 536","GSM307313","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307313/GSM307313.gpr.gz","","","33091"
"GSM307314","tumor sample 539","GSM307314","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307314/GSM307314.gpr.gz","","","33091"
"GSM307315","tumor sample 542","GSM307315","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307315/GSM307315.gpr.gz","","","33091"
"GSM307316","tumor sample 543","GSM307316","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307316/GSM307316.gpr.gz","","","33091"
"GSM307317","tumor sample 544","GSM307317","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307317/GSM307317_H059F7.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307317/GSM307317_H059I2.gpr.gz","","33091"
"GSM307318","tumor sample 547","GSM307318","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CA","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307318/GSM307318.gpr.gz","","","33091"
"GSM307319","tumor sample 565","GSM307319","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307319/GSM307319.gpr.gz","","","33091"
"GSM307320","tumor sample 567","GSM307320","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307320/GSM307320.gpr.gz","","","33091"
"GSM307321","tumor sample 568","GSM307321","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307321/GSM307321.gpr.gz","","","33091"
"GSM307322","tumor sample 569","GSM307322","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307322/GSM307322.gpr.gz","","","33091"
"GSM307323","tumor sample 571","GSM307323","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307323/GSM307323.gpr.gz","","","33091"
"GSM307324","tumor sample 572","GSM307324","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307324/GSM307324.gpr.gz","","","33091"
"GSM307325","tumor sample 575","GSM307325","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307325/GSM307325.gpr.gz","","","33091"
"GSM307326","tumor sample 608","GSM307326","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307326/GSM307326_H059H9.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307326/GSM307326_H059I1.gpr.gz","","33091"
"GSM307327","tumor sample 609","GSM307327","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: TisN0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307327/GSM307327_H059H7.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307327/GSM307327_H059I3.gpr.gz","","33091"
"GSM307328","tumor sample 613","GSM307328","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: TisN0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307328/GSM307328.gpr.gz","","","33091"
"GSM307329","tumor sample 614","GSM307329","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: CA","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307329/GSM307329.gpr.gz","","","33091"
"GSM307330","tumor sample 617","GSM307330","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: TisN0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307330/GSM307330.gpr.gz","","","33091"
"GSM307331","tumor sample 618","GSM307331","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307331/GSM307331.gpr.gz","","","33091"
"GSM307332","tumor sample 621","GSM307332","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TEM treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307332/GSM307332.gpr.gz","","","33091"
"GSM307333","tumor sample TME1124","GSM307333","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N3","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307333/GSM307333.gpr.gz","","","33091"
"GSM307334","tumor sample TME1183","GSM307334","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307334/GSM307334.gpr.gz","","","33091"
"GSM307335","tumor sample TME1203","GSM307335","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307335/GSM307335.gpr.gz","","","33091"
"GSM307336","tumor sample TME1208","GSM307336","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N1","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307336/GSM307336.gpr.gz","","","33091"
"GSM307337","tumor sample TME122","GSM307337","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: AC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307337/GSM307337.gpr.gz","","","33091"
"GSM307338","tumor sample TME1249","GSM307338","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307338/GSM307338.gpr.gz","","","33091"
"GSM307339","tumor sample TME1344","GSM307339","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307339/GSM307339_H059H3.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307339/GSM307339_H059I0.gpr.gz","","33091"
"GSM307340","tumor sample TME161","GSM307340","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: AA","Stage: TisN0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307340/GSM307340.gpr.gz","","","33091"
"GSM307341","tumor sample TME209","GSM307341","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N3","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307341/GSM307341.gpr.gz","","","33091"
"GSM307342","tumor sample TME247","GSM307342","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307342/GSM307342.gpr.gz","","","33091"
"GSM307343","tumor sample TME271","GSM307343","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307343/GSM307343.gpr.gz","","","33091"
"GSM307344","tumor sample TME277","GSM307344","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307344/GSM307344.gpr.gz","","","33091"
"GSM307345","tumor sample TME30","GSM307345","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N1","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307345/GSM307345.gpr.gz","","","33091"
"GSM307346","tumor sample TME310","GSM307346","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307346/GSM307346.gpr.gz","","","33091"
"GSM307347","tumor sample TME321","GSM307347","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CA","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307347/GSM307347.gpr.gz","","","33091"
"GSM307348","tumor sample TME338","GSM307348","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307348/GSM307348.gpr.gz","","","33091"
"GSM307349","tumor sample TME365","GSM307349","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307349/GSM307349.gpr.gz","","","33091"
"GSM307350","tumor sample TME382","GSM307350","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N1","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307350/GSM307350.gpr.gz","","","33091"
"GSM307351","tumor sample TME385","GSM307351","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N2","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307351/GSM307351.gpr.gz","","","33091"
"GSM307352","tumor sample TME420","GSM307352","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: AA","Stage: T0N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307352/GSM307352.gpr.gz","","","33091"
"GSM307353","tumor sample TME498","GSM307353","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N2","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307353/GSM307353.gpr.gz","","","33091"
"GSM307354","tumor sample TME523","GSM307354","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307354/GSM307354.gpr.gz","","","33091"
"GSM307355","tumor sample TME535","GSM307355","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: AA","Stage: TisN0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307355/GSM307355.gpr.gz","","","33091"
"GSM307356","tumor sample TME593","GSM307356","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307356/GSM307356.gpr.gz","","","33091"
"GSM307357","tumor sample TME598","GSM307357","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307357/GSM307357.gpr.gz","","","33091"
"GSM307358","tumor sample TME603","GSM307358","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307358/GSM307358.gpr.gz","","","33091"
"GSM307359","tumor sample TME607","GSM307359","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307359/GSM307359.gpr.gz","","","33091"
"GSM307360","tumor sample TME623","GSM307360","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N2","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307360/GSM307360.gpr.gz","","","33091"
"GSM307361","tumor sample TME625","GSM307361","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307361/GSM307361_H071H2.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307361/GSM307361_H071H6.gpr.gz","","33091"
"GSM307362","tumor sample TME650","GSM307362","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CA","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307362/GSM307362.gpr.gz","","","33091"
"GSM307363","tumor sample TME658","GSM307363","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: AC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307363/GSM307363.gpr.gz","","","33091"
"GSM307364","tumor sample TME674","GSM307364","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307364/GSM307364.gpr.gz","","","33091"
"GSM307365","tumor sample TME715","GSM307365","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N1","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307365/GSM307365.gpr.gz","","","33091"
"GSM307366","tumor sample TME739","GSM307366","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307366/GSM307366.gpr.gz","","","33091"
"GSM307367","tumor sample TME747","GSM307367","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N1","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307367/GSM307367.gpr.gz","","","33091"
"GSM307368","tumor sample TME772","GSM307368","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T1N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307368/GSM307368.gpr.gz","","","33091"
"GSM307369","tumor sample TME884","GSM307369","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307369/GSM307369_H071G9.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307369/GSM307369_H071H7.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307369/GSM307369_H071I1.gpr.gz","33091"
"GSM307370","tumor sample TME890","GSM307370","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: AC","Stage: T2N0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307370/GSM307370.gpr.gz","","","33091"
"GSM307371","tumor sample TME896","GSM307371","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: CC(N)","Stage: T2N2","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307371/GSM307371.gpr.gz","","","33091"
"GSM307372","tumor sample TME947","GSM307372","Public on Oct 21 2008","Jul 24 2008","Oct 21 2008","RNA","2","tumor sample","Homo sapiens","Rectal tumor tissue","TME treated","Group: AA","Stage: TisN0","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy5","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Reference material consisting of pooled RNAs isolated from five colorectal cancer cell lines (HCT116, LS411N, SW480, HCT15, Caco2) and five normal rectum samples.","Homo sapiens","reference","total RNA","Total RNA extracted using Trizol following manufacturer's instructions","Cy3","Two ug of total RNA was amplified and labeled using Ambion's Amino Allyl MessageAmp™ aRNA kit and protocol (Ambion Inc., Austin, TX). For each microarray experiment, 2.0-μg aliquots of aRNA were labeled with Cy5 (Amersham Biosciences, Buckinghamshire, UK). The labeled aRNAs were mixed with equal amounts of Cy3-labeled reference aRNA. To the mixture of labeled reference and sample RNA, 20 μg human COT-1 DNA (Invitrogen, Carlsbad, CA), 8 μg yeast tRNA (Invitrogen) and 20 μg polyadenylic acid (Sigma-Aldrich, St. Louis, MO) were added.","9606","Preheated hybridization buffer (25% formamide, 5× SSC, 0.1% SDS) was added and arrays were hybridised overnight 42°C to human 35K oligo microarrays","Scanned on an Agilent G2565BA scanner.","Expanded descriptions of Channel 1 'Characteristics':","TEM: transanal endoscopic microsurgical resection. TME: total mesorectal excision","AA: pure adenomas(in paper A/A), AC: adenoma fraction from cases with a carcinoma focus(in paper A/C), CA: tumor fractions consisting of a mixture of adenoma and carcinoma tissue(in paper AC/C), CC: carcinomas without lymph node metastasis(in paper C/C), CC(N): carcinomas with lymph node metastasis(in paper C/C(N+)).","The stages (T1N0) represent the TNM classification of colorectal tumors (International Union Against Cancer (UICC)).","Images were quantified using Genepix 5.1 Software. The Limma (linear models for microarray data) package of Bioconductor (http://www.bioconductor.org) was used for importing the data, normalizing the arrays and identifying differentially expressed genes. Control spots and spots with more than 10% saturation, a diameter smaller than 60 μm or signal intensity less than 20 counts above background were excluded from the analysis. Data were corrected for local background (method normexp) and normalized within arrays by print-tip loess normalization and between arrays by quantile normalization.","GPL3676","Esther,,Lips","e.lips@nki.nl","+31-20-5122039","+31-20-5122050","Experimental Therapy","NKI-AVL","Plesmanlaan 121","Amsterdam","1066 CX ","Netherlands","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307372/GSM307372_H059G2.gpr.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307372/GSM307372_H059H6.gpr.gz","","33091"
